GlassScriptPhysician profile
Hemendra S Parikh
NPI 1841385952
$377.51
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $19.52 · 2022: $25.86.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $113.33 | 2019 | |
| Ekos Corporation | $75.00 | 2019 | |
| Ironshore Pharmaceuticals INC. | $41.83 | 2019-2020 | |
| Rhodes Pharmaceuticals L.P. | $31.23 | 2019 | |
| Adlon Therapeutics L.P. | $28.80 | 2019 | |
| Organogenesis INC. | $25.86 | 2022 | |
| Pfizer INC. | $23.61 | 2019 | |
| Cranial Technologies, INC | $14.49 | 2019 | |
| Radiometer America, INC | $12.43 | 2019 | |
| Tris Pharma INC | $10.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemendra Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.